Does capecitabine maintenance therapy versus active monitoring confer a survival benefit after first-line treatment of metastatic colorectal cancer? A meta-analysis of randomized controlled trialsLing Fan, Bobo Zheng, Ying Jie et al.|Research Square|2022Cited by 0